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Objectives. To evaluate alterations in sexual function and genital sensitivity after anastomotic repair (AR) and free grafturethroplasty
(FGU) for bulbar urethral strictures. Methods. Patients treated with AR (𝑛 = 31) or FGU (𝑛 = 16) were prospectively evaluated
before, 6 weeks and 6 months after urethroplasty. Evaluation included International Prostate Symptom Score (IPSS), 5-Item
International Index of Erectile Function (IIEF-5), Ejaculation/Orgasm Score (EOS), and 3 questions on genital sensitivity. Results.
At 6 weeks, there was a significant decline of IIEF-5 for AR (−4.8; 𝑝 = 0.005), whereas there was no significant change for FGU
(+0.9; 𝑝 = 0.115). After 6 months, differences with baseline were not significant overall and among subgroups. At 6 weeks, there
was a significant decline in EOS for AR (−1.4; 𝑝 = 0.022). In the FGU group there was no significant change (+0.6; 𝑝 = 0.12).
Overall and among subgroups, EOS normalized at 6 months. After 6 weeks and 6 months, respectively, 62.2 and 52% of patients
reported alterations in penile sensitivity with no significant differences among subgroups. Conclusions. AR is associated with a
transient decline in erectile and ejaculatory function. This was not observed with FGU. Bulbar AR and FGU are likely to alter
genital sensitivity.
1. Introduction
Although a short bulbar stricture can be treated by dilation
or endoscopic urethrotomy, longer or recurrent strictures are
best treated by urethroplasty as it provides the best chance
of success [1–3]. Anastomotic repair (AR) and free graft
urethroplasty (FGU) are established treatments for bulbar
strictures with the choice of technique mainly depending
on stricture length [1, 3, 4]. The main goal of urethroplasty
is to restore urethral patency, and, as a consequence, most
papers have focused on this criterion to evaluate success
of urethroplasty [1, 3, 5]. In the past decade, there is an
upcoming concern that especially bulbar urethroplastymight
affect sexual functioning [6–8]. The aim of this paper is to
evaluate and compare sexual function after AR and FGU for
bulbar strictures in a prospective fashion.
2. Materials and Methods
2.1. Patient Recruitment. Out of 258 male patients who
underwent urethroplasty between October 2010 and Febru-
ary 2014, 90 patientswith a bulbar stricture onlywere planned
to be treated with AR or FGU and eligible to participate in
this prospective study. Only native Dutch speaking patients
who signed the informed consent (Institutional Review
Board Approval EC UZG 2008/234) and who filled in the
preoperative questionnaires and at least one postoperative
questionnaire (at 6 weeks and/or 6 months) were included
in this analysis. Finally, 47 patients were included for further
analysis and divided into two groups: AR (𝑛 = 31) versus
FGU (𝑛 = 16) (Figure 1). Prepuce and oral mucosa was
used as graft in, respectively, 12 and 4 patients. Stricture
location and stricture length were evaluated by retrograde
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Male urethroplasty, October 2010–February 2014 
Exclusion on stricture location:
Posterior 
Penile
Combined penile-bulbar
Exclusion on type of bulbar urethroplasty: 
Augmented anastomotic repair
2-stage urethroplasty
Heineke-Mikulicz repair
Bulbar urethroplasty with the following:
Anastomotic repair
Free graft urethroplasty
Further exclusion on:
No informed consent
No native Dutch speaking
Being lost to follow-up
Final analysis:
Anastomotic repair
Free graft urethroplasty
N = 258
N = 35
N = 86
N = 32
N = 5
N = 8
N = 2
N = 13
N = 20
N = 10
N = 31
N = 16
N = 52
N = 38
Figure 1: Flowchart of patient inclusion.
urethrography. This study included the following evalua-
tions:
(i) urinary symptoms: maximum urinary flow (𝑄max)
and the International Prostate Symptom Score (IPSS)
questionnaire; the IPSS ranges from 0 (no lower
urinary tract symptoms) to 35 (severe lower urinary
tract symptoms);
(ii) erectile function: the abridged 5-item version of the
International Index of Erectile Function (IIEF-5) [9];
this score ranges from 1 (no sexual intercourse) to 25
(no erectile dysfunction);
(iii) ejaculation/orgasm: the sum of questions 9 and 10
from IIEF (long version) [10]; this Ejaculation/Or-
gasm Score (EOS) ranges from 2 (no ejaculation/or-
gasm) to 10 (normal ejaculation and orgasm);
(iv) postoperative genital sensitivity: a nonvalidated in-
house questionnaire containing 3 dichotomous ques-
tions on glans tumescence, alterations in genital
sensitivity, and cold feeling in the glans; further
analysis of glans tumescencewas only done in patients
reporting normal erectile function (IIEF-5 ≥ 20) in
order to avoid contamination of diminished glans
tumescence due to globally diminished penile tumes-
cence.
Patients were evaluated preoperatively, after 6 weeks and
6 months. In the first six months, no phosphodiesterase-
5 inhibitors were prescribed to stimulate sexual rehabilita-
tion. In case of suspicion of stricture recurrence (𝑄max <
15mL/s and/or IPSS > 19), retrograde urethrography and
urethroscopy were done. A functional definition of failure
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Table 1: Patients’ characteristics (SD = standard deviation; FGU = free graft urethroplasty; AR = anastomotic repair; DVIU = direct vision
internal urethrotomy; 𝑄max = maximum urinary flow; IPSS = International Prostate Symptom Score; IIEF = International Index of Erectile
Function; EOS = Ejaculation/Orgasm Score).
All
(𝑛 = 47)
FGU
(𝑛 = 16)
AR
(𝑛 = 31) 𝑝 value
Age (years) Mean (SD) 40 (16) 48 (18) 37 (13) 0.018
Follow-up (months) Mean (SD) 23.3 (10.9) 25.2 (12.5) 22.2 (10) 0.376
Stricture length (cm) Mean (SD) 3 (2.4) 5.4 (2.6) 1.8 (0.8) <0.001
Stricture etiology
Traumatic Number (%) 4 (8.5) 0 (0) 4 (12.9)
0.071Inflammatory Number (%) 1 (2.1) 0 (0) 1 (3.2)
Iatrogenic Number (%) 14 (29.8) 8 (50) 6 (19.4)
Idiopathic Number (%) 28 (59.6) 8 (50) 20 (64.5)
Previous interventions
None Number (%) 4 (8.5) 2 (12.5) 2 (6.5)
0.877DVIU/dilation(s) Number (%) 34 (72.3) 11 (68.8) 23 (74.2)
Urethroplasty(ies) Number (%) 9 (19.1) 3 (18.8) 6 (19.4)
Preop 𝑄max (mL/s) Mean (SD) 6.3 (4.6) 6.9 (4) 6 (5) 0.629
Preop IPSS (. . ./35) Mean (SD) 22 (8) 23 (7) 21 (8) 0.368
Preop IIEF-5 (. . ./25) Mean (SD) 20 (7) 18 (8) 22 (6) 0.202
Preop EOS (. . ./10) Mean (SD) 8 (3) 7 (4) 9 (3) 0.135
Suprapubic catheter
Yes Number (%) 8 (17) 2 (12.5) 6 (19.4) 0.697
No Number (%) 39 (83) 14 (87.5) 25 (80.6)
was used which includes the need for any additional urethral
manipulation (including dilation) [11].
2.2. Surgical Technique. Patients were operated on in a
single center (GUH) by two surgeons (Nicolaas Lumen
and Willem Oosterlinck). AR was preferred whenever a
tension-free anastomosis could be made (stricture length <
3 cm on urethrography and/or peroperative findings). For
longer strictures, FGU was performed. For both techniques,
a midline perineal incision is made; the bulbospongiosus
muscle is incised at the midline and dissected away from the
corpus spongiosum. In case of AR, the corpus spongiosum
is circumferentially freed at the level of the stricture. The
corpus spongiosum and urethra are transected at this site.
The fibrotic urethra and spongiosus edges are resected until
healthy urethra is present at both the distal and proximal
ends.The urethra is then spatulated in order to obtain a broad
oblique anastomosis, which is finalized by 8–10 interrupted
resorbable 4.0 sutures. In case of FGU, the stricture is opened
ventrally on the tip of the catheter. The stricture length
is measured and a graft is taken accordingly. The graft is
sutured into the urethra in a ventral onlay fashion.The corpus
spongiosum is closed over the graft for vascular supply and
mechanical support (spongioplasty). The urethral catheter is
maintained for 14 days and a voiding cystourethrogram is
made upon removal.
2.3. Statistical Analysis. Descriptive statistics were performed
to evaluate the whole population and both subgroups. To
compare both groups, continuous variables were evaluated
by independent-samples 𝑡-test or the Welch modified 𝑡-test
for, respectively, equal and unequal distributions. Categorical
variables were evaluated by chi-square or Fischer’s exact
test. The 2-year recurrence-free survival was estimated by
Kaplan-Meier statistics and groups were compared by log
rank statistics. To evaluate changes in IPSS, IIEF-5 score, and
EOS between baseline and at 6 weeks and 6 months, mean
differences were calculated by paired-samples 𝑡-test.
3. Results
Patients treated by AR were significantly younger (37 versus
48 years; 𝑝 = 0.018) and strictures were shorter with AR
compared to FGU (1.8 versus 5.4 cm; 𝑝 < 0.001). Both groups
were comparable for follow-up duration, stricture etiology,
previous interventions, and presence of suprapubic catheter
and for preoperative urinary flow, IPSS, IIEF-5, and EOS
(Table 1). After a mean follow-up of 23 months, 6 patients
(12.8%) suffered a recurrence: 3 (9.7%) patients treated with
AR and 3 (18.8%) patients treated with FGU (𝑝 = 0.395).
Estimated 2-year recurrence-free survival rate was 93% and
72%, respectively, for AR and FGU (𝑝 = 0.347). Overall
and in both groups, there was a significant improvement of
the urinary flow at latest follow-up. Accordingly, there was a
significant improvement in IPSS after 6 weeks and 6 months
overall and in both groups (Table 2; Figure 2(a)).
Thirty-three patients, respectively, 19 and 14 patients in
the AR- and FGU-group, reported to have sexual intercourse
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Table 2: Mean paired differences (Δ) of the maximum urinary flow (𝑄max) and International Prostate Symptom Score (IPSS). The standard
deviation is provided between brackets (FGU = free graft urethroplasty; AR = anastomotic repair).
Δ𝑄max (mL/s) 𝑝 value
ΔIPSS (6 weeks
versus preop) 𝑝 value
ΔIPSS (6 months
versus preop) 𝑝 value
All +19.8 (13.9) <0.001 −17 (8) <0.001 −20 (9) <0.001
FGU +13.8 (11.7) 0.007 −16 (10) <0.001 −21 (8) <0.001
AR +22.3 (14.3) <0.001 −17 (7) <0.001 −20 (9) <0.001
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Figure 2: Evolution of International Prostate Symptom Score (a), International Index of Erectile Function-5 (b), and Ejaculation/Orgasm
Score (c) for all patients and subdivided for anastomotic repair (AR) and free graft urethroplasty (FGU) (∗𝑝 < 0.05).
and filled in the IIEF-5 (Table 3; Figure 2(b)). Overall, there
was a significant decline in IIEF-5 score after 6 weeks (−2.3;
𝑝 = 0.026). This decline remained significant for AR (−4.8;
𝑝 = 0.005). However, for FGU, there was no significant
change in IIEF-5 score (+0.9; 𝑝 = 0.115). After 6 months,
there were no longer significant changes in IIEF-5 score
overall (−0.2; 𝑝 = 0.907), for AR (−2.1; 𝑝 = 0.263) and for
FGU (+2.3; 𝑝 = 0.313).
Thirty-seven patients, respectively, 23 and 14 patients in
the AR- and FGU-group, tried to have ejaculation/orgasm
(by masturbation or sexual intercourse) and completed the
EOS (Table 3; Figure 2(c)). Overall, there was no significant
postoperative change in EOS at 6 weeks (−0.7; 𝑝 = 0.111).
However, in the AR-group there was a significant decline in
EOS (−1.4; 𝑝 = 0.022). This was not the case in the FGU-
group (+0.6; 𝑝 = 0.12). After 6 months, EOS returned to
baseline. The decline for AR (−0.4; 𝑝 = 0.431) was no longer
significant.
At 6 weeks and 6 months, respectively, 45 and 25 patients
filled in the questionnaire on genital sensitivity and on cold
feeling in the glans. At 6 weeks, 28 patients (62.2%) reported
to have altered genital sensitivity. This proportion was not
significantly different between AR and FGU (66.7 versus
53.3%;𝑝 = 0.517). Only one patient, treated byAR, had a cold
feeling in the glans. At 6 months, 13 patients (52%) reported
to have altered genital sensitivity. Again, this proportion was
not significantly different with AR compared to FGU (58.8%
versus 37.5%; 𝑝 = 0.411). At 6months, no one reported a cold
feeling in the glans. Of 20 patients with IIEF-5 ≥ 20 at 6 weeks
1/10 (10%) and 4/10 (40%) of patients in, respectively, the AR-
and FGU-groups reported no glans tumescence (𝑝 = 0.303).
At 6 months, 1/6 (16.7%) and 3/5 (60%) patients with IIEF-
5 ≥ 20, respectively, treated by AR and FGU reported no
glans tumescence (𝑝 = 0.242). Of the 4 patients treated with
oral mucosa, 2 had altered genital sensitivity and no glans
tumescence at 6 weeks and 6 months.
4. Discussion
Although this series is a prospective study, no randomization
was done between AR and FGU because the use of AR is
limited by the stricture length. The limit for AR is usually
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Table 3: Mean paired differences (Δ) of the 5-Item International Index of Erectile Function (IIEF-5) and Ejaculation/Orgasm Score (EOS).
The standard deviation is provided between brackets (FGU = free graft urethroplasty; AR = anastomotic repair).
ΔIIEF-5 (6 weeks
versus preop) 𝑝 value
ΔIIEF-5 (6 months
versus preop) 𝑝 value
All 𝑛 = 33 −2.3 (5.8) 0.026 𝑛 = 18 −0.2 (6) 0.907
FGU 𝑛 = 14 +0.9 (2) 0.115 𝑛 = 8 +2.3 (5.8) 0.313
AR 𝑛 = 19 −4.8 (6.5) 0.005 𝑛 = 10 −2.1 (5.6) 0.263
ΔEOS (6 weeks versus
preop) 𝑝 value
ΔEOS (6 months
versus preop) 𝑝 value
All 𝑛 = 37 −0.7 (2.5) 0.111 𝑛 = 22 0 (1.9) 1
FGU 𝑛 = 14 +0.6 (1.3) 0.12 𝑛 = 8 +0.6 (2.2) 0.448
AR 𝑛 = 23 −1.4 (2.8) 0.022 𝑛 = 14 −0.4 (1.6) 0.431
set at 2-3 cm [4, 12]. This also explains why strictures treated
with AR were significantly shorter compared to FGU in
this series. Another difference between both groups was
younger patient’s age with AR. For this observation, we
have the following explanation: patients treated with AR
have shorter strictures (cf. supra) and short bulbar strictures
are predominantly idiopathic/congenital in origin and thus
occurring at a younger age [13]. Despite these differences in
age and stricture length between AR and FGU, preoperative
erectile and orgasmic function was not significantly different
between these groups. It has been reported that longer
stricture length and more advanced patient age are more
likely to be associated with postoperative erectile dysfunction
(ED) [14–16]. The observed difference in patient age and
stricture length would thus be in favor of AR in terms of
postoperative erectile function. This has not been observed
in this series, on the contrary.
The success rate of 90.3% for AR in this series is in
line with the 93.8% composite success rate reported by
the SIU/ICUD consultation [1]. For longer strictures at the
bulbar urethra, FGU is the preferred technique of substitution
urethroplasty as flaps are associated with more morbidity [3].
Our 81.2% success rate of ventral FGU is again in line with
the overall 88.8% success rate reported by the SIU/ICUD
consultation [3]. Because of its excellent success rate, the
SIU/ICUD consultation recommends AR as optimal treat-
ment for short bulbar strictures [1]. This recommendation
is questioned because of a potential higher risk of sexual
dysfunction related to AR [17].
An increasing number of papers report on sexual dys-
function after urethroplasty [6–8, 18]. Although the results
are far from uniform, there is a trend for a higher inci-
dence of sexual dysfunction after AR compared to FGU.
Palminteri et al. found that 35% and 65% of patients treated
by FGU reported improvement in erectile and ejaculatory
function [8]. This is in line with our results revealing a
trend to improvement in erectile and orgasmic function in
the FGU-group. Al-Qudah and Santucci reported ED as late
complication in 17% of patients after AR but no ED after
FGU [18]. In their prospective study, Erickson et al. found
the highest incidence of ED (50%) in the group treated by
AR, compared to FGU, where only 26% of patients suffered
from ED. However, these differences were not statistically
significant [7]. In their logistic regression model, Xie et al.
reported that the method of treatment is a significant factor
to predict for postoperative ED, with the highest risk of ED
for AR [6].
Other authors did not find a significant decline in erectile
function [19, 20] nor did they find a difference between AR
and FGU [15, 16, 21, 22]. These contradictory results can
be explained by several factors. First, timing of evaluation
seems to be very important. Erickson et al. found a significant
worse erectile function when evaluation is done <1 year after
urethroplasty [15]. Xie et al. found a significant decline of
erectile function with AR after 3 months but a normalization
after 6 months [6]. This was also noted by Mundy, who
found ED in 53% and 33% of patients after AR and FGU,
respectively, at a 3-month follow-up. This decreased to 5%
and 0.9% after longer follow-up [23]. In the AR-group, we
also found a transient decline in erectile function after 6
weeks with recuperation after 6 months.Therefore, it is likely
that if erectile function is at earliest assessed >3 months after
urethroplasty [19, 22], a transient decline in erectile function
might have been missed. Secondly, the evaluation tool to
assess erectile function might be important. The IIEF-5 is a
validated questionnaire to assess erectile function and was
therefore used in this series. Other authors, however, used an
in-house questionnaire with dichotomous answers (erectile
dysfunction present or absent) [16, 19, 22]. Other factors that
might be important to explain contradictory findings among
studies are retrospective evaluation (with risk of recall bias)
[9, 16, 19, 22] and small patient groups [21].
We speculate that the observed transient decline in
erectile function with AR might be related to the following:
(i) more extensive and circumferential dissection of the
corpus spongiosum containing the bulbar urethra;
proximal dissection and mobilization of the cor-
pus spongiosum nearby the urogenital diaphragm
and in the intracrural space might provoke neu-
ropraxia and/or thermal damage (coagulation) of
erectile nerves penetrating the corporal bodies at
that location (Figure 3); this hypothesis is supported
by neuroanatomical findings reported by Yucel and
Baskin [24] and Akman et al. [25];
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(a) (b)
Figure 3: Peroperative photographs of AR (a) and FGU (b): a more extensive dissection with AR can be appreciated; 1: circumferentially
mobilized bulbar urethra; 2: transected urethra; ∗: region where erectile nerves are expected; and 3: ventrally opened bulbar urethra.
(ii) complete transection of the corpus spongiosum that
might be associated with a higher risk of bleeding and
with postoperative haematoma and inflammation;
this needs some time to recover; this might withhold
patients to have satisfactory sexual activity or might
provoke psychological problems.
In this series, ventral FGUwas performed, with no significant
decrease in sexual functioning at 6 weeks and 6 months. It
would be interesting to know whether dorsal FGU affects
sexual functioning. One would expect a higher incidence of
sexual dysfunction if the hypothesis of more extensive and
circumferential dissection of the bulbar corpus spongiosum
is (in part) responsible for sexual dysfunction.
In this series, a transient decline in EOSwas seenwithAR,
whereas there was no significant difference observed with
FGU. Erickson et al. found an improvement of ejaculatory
function after urethroplasty (mix of AR and FGU) [15],
but a later prospective study failed to show any significant
changes in ejaculatory function after urethroplasty (also mix
of AR and FGU) [26]. Improvement of ejaculatory function
after urethroplasty might be related to desobstruction of
the urethra [26]. However this cannot explain the transient
decline in ejaculatory function after AR that was seen
in our series. Barbagli et al. also reported postoperative
ejaculatory dysfunction in 23.3% of patients treated with
AR [19]. We hypothesize that the higher rate of ejaculatory
dysfunction associated with AR is because of the more
extensive detachment of the bulbospongiosus muscle in AR
needed for a full mobilization of the bulbar urethra. This
detachment can indeed interfere with ejaculatory function.
Timing of questioning might again be important: recovery
of postoperative ejaculatory dysfunction can be expected
once the bulbospongiosus muscle has recovered from the
surgical trauma. This cannot be expected after 6 weeks but
can be expected after 6 months. Another explanation is that
ejaculatory and orgasmic dysfunction is related to ED, which
was also more frequent after AR.
In this series, postoperative changes in genital sensitivity
were present in approximately 2 out of 3 and 1 out of 2
patients after, respectively, 6 weeks and 6 months. Changes
in genital sensitivity were not significantly different among
subgroups. Palminteri et al. found a change in genital sen-
sitivity after FGU in 50% of patients [8]. This is in line
with our findings, but substantially higher than the 18.3%
reported rate by Barbagli et al. [19]. However, this was a
retrospective series with a possible risk of underreporting.
In the same series [19], only one patient (1.6%) reported a
cold glans, which is in concordance with the finding in our
series. Postoperative changes in genital sensitivity might be
explained by postoperative haematoma formation, oedema,
and inflammation. Furthermore, in the majority of patients
treated by FGU, a preputial skin graft was used.These factors
might certainly explain the high rate of early (6 weeks)
changes in genital sensitivity. However, even after 6 months,
changes in genital sensitivity were still frequently reported,
and this occurs also in patients treated with oral mucosa.This
might be explained by damage to some sensory branches of
the perineal nerves that supply the ventral surface of the penis
[24]. By transecting the entire corpus spongiosum, onewould
expect a higher rate of impaired glans tumescence after AR.
This was not observed in this series. However, interpretation
of the results is hampered by the small number of patients.
This series again underlines the concern of possible
alterations in sexual functioning and genital sensitivity
after bulbar urethroplasty. Therefore it should be part of
the evaluation of patients treated by urethroplasty. Jackson
et al. recently validated patient reported outcome measures
(PROMs) for urethroplasty [27]. However, this PROM lacks
a section on sexual functioning.
Furthermore, it would be interesting to evaluate whether
modifications in urethroplasty techniques such as muscle-
and nerve-sparing bulbar urethroplasty [28] and vessel-
sparing anastomotic repair [29] will be associated with less
sexual dysfunction.
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Important limitations of the present series are the small
sample size and the missing data in the postoperative ques-
tionnaires.
5. Conclusions
AR is associated with a transient decline in erectile and
ejaculatory function. This was not observed with FGU.
Bulbar urethroplasty is likely to provoke changes in genital
sensitivity. Further prospective studies with validated and
internationally accepted patient reported outcome measures
(PROMs) are needed for further confirmation.
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